Related Experiment Video
Updated: Jun 10, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Tracking tumor evolution via prostate-specific antigen: an individual post-operative study
1Laboratory for Solid State Physics, ETH Zurich, CH-8093 Zurich, Switzerland. erbudak@phys.ethz.ch
Theoretical Biology & Medical Modelling
|August 3, 2010
Summary
Prostate-specific antigen (PSA) levels after surgery reveal a shift in tumor growth dynamics. This study is the first to analyze PSA progression to understand prostate cancer cell behavior post-prostatectomy.
Area of Science:
- Oncology
- Biophysics
- Mathematical Biology
Background:
- Prostate-specific antigen (PSA) levels are routinely monitored after radical prostatectomy to assess tumor recurrence and growth.
- Understanding the kinetics of PSA progression can provide insights into prostate cancer cell behavior and tumor dynamics.
- This study pioneers the analysis of PSA level progression to characterize tumor cell growth modes.
Purpose of the Study:
- To investigate the mode of prostate tumor cell growth by analyzing the progression of prostate-specific antigen (PSA) levels post-radical prostatectomy.
- To identify potential transitions in tumor growth kinetics based on serial PSA measurements.
Main Methods:
- Regular determination of prostate tumor marker (PSA) values after surgery.
- Plotting PSA values on a logarithmic scale against time to analyze growth kinetics.
- Mathematical modeling to associate observed PSA changes with tumor cell growth modes.
Main Results:
- PSA levels exhibited an initial rapid-growth phase after surgery.
- A transition to a slower power-law growth regime was observed within two years.
- This transition is hypothesized to represent a shift from dispersed cell growth to macroscopic cell clumping.
Conclusions:
- The observed changes in PSA kinetics suggest a transition in prostate tumor cell growth modes.
- Characterizing these growth dynamics may inform the timing of postoperative therapies.
- Optimizing therapeutic windows could potentially improve patient life expectancy.

